![Marit Sjo Lorentzen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marit Sjo Lorentzen
Chief Operating Officer at
ARCTICZYMES TECHNOLOGIES ASA
Net worth: 63 474 $ as of 2026-09-29
Profile
Marit Sjo Lorentzen currently works at Biotec BetaGlucans AS, as Director and ArcticZymes Technologies ASA, as Vice President-Operations.
Dr. Lorentzen received her doctorate degree in 2005 from the University of Tromso.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-30 | 29,831 ( 0.06% ) | 63 474 $ | 2026-09-29 |
Marit Sjo Lorentzen active positions
| Companies | Position | Start |
|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Chief Operating Officer | - |
Biotec BetaGlucans AS
 Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Director/Board Member | - |
Education of Marit Sjo Lorentzen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
ArcticZymes Technologies ASA
 ArcticZymes Technologies ASA Medical SpecialtiesHealth Technology Develops and manufactures immune modulating compounds | Health Technology |
University of Tromso
 University of Tromso Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotec BetaGlucans AS
Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Develops and manufactures immune modulating compounds for the human health sectors | Health Technology |
- Stock Market
- Insiders
- Marit Sjo Lorentzen
